Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    Immunomodulation and Therapeutic Effects of a Monotherapy with Interleukin-2 as an Induction Therapy in Patients with Poor-Prognosis Acute Myeloid Leukemia

    IL-2 has been shown to induce several mechanisms of MHC-restricted and MHC-unrestricted cytotoxicity against leukemic blasts in vitro and in vivo. Also it is known that patients with AML have a reduced or defe...

    D. L. Voliotis, S. Schmitz, P. Staib, H. Tesch, V. Diehl in Acute Leukemias VII (1998)